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A Novel Transwell Blood Brain
Barrier Model Using Primary
Human Cells
Nicole L. Stone* , Timothy J. England and Saoirse E. O’Sullivan
Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, University of Nottingham,
Nottingham, United Kingdom
Structural alterations and breakdown of the blood brain barrier (BBB) is often a primary
or secondary consequence of disease, resulting in brain oedema and the transport
of unwanted substances into the brain. It is critical that effective in vitro models
are developed to model the in vivo environment to aid in clinically relevant research,
especially regarding drug screening and permeability studies. Our novel model uses only
primary human cells and includes four of the key cells of the BBB: astrocytes, pericytes,
brain microvascular endothelial cells (HBMEC) and neurons. We show that using a larger
membrane pore size (3.0 µM) there is an improved connection between the endothelial
cells, astrocytes and pericytes. Compared to a two and three cell model, we show
that when neurons are added to HBMECs, astrocytes and pericytes, BBB integrity was
more sensitive to oxygen-glucose deprivation evidenced by increased permeability and
markers of cell damage. Our data also show that a four cell model responds faster
to the barrier tightening effects of glucocorticoid dexamethasone, when compared to
a two cell and three cell model. These data highlight the important role that neurons
play in response to ischaemia, particularly how they contribute to BBB maintenance
and breakdown. We consider that this model is more representative of the interactions
at the neurovascular unit than other transwell models and is a useful method to study
BBB physiology.
Keywords: blood-brain barrier, transwell, in vitro, BBB model, BBB permeability, primary human cells, stroke
INTRODUCTION
The blood brain barrier (BBB) is a unique interface that separates the peripheral blood supply and
neuronal tissue. Structurally, the BBB is comprised of specialized brain microvascular endothelial
cells (HBMECs), perivascular cells (pericytes) and astrocytes (Abbott et al., 2006, 2010). Neurons
and microglia also contribute to the maintenance of the BBB and form what is known as the
neurovascular unit (NVU) (Abbott et al., 2006). Pericytes contribute 22–32% of the cerebral
vasculature and together with vascular smooth muscle cells and endothelial cells they maintain
vascular function (Martini and Bartholomew, 2017). In the CNS, pericytes are present at a higher
ratio to HBMECs in the brain compared to the periphery and recent studies have shown the
extensive role of pericytes in BBB development and maintenance (Kacem et al., 1998; Armulik
et al., 2011; Sweeney et al., 2016). As well as offering mechanical support, they also regulate
vessel contractility, endothelial proliferation, blood flow and angiogenesis (Bergers and Song, 2005;
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Dore-Duffy, 2008). Pericytes have also been shown to secrete
angiogenic factors such as vascular endothelial growth factor
(VEGF), that support endothelial cell survival and proliferation
(Darland et al., 2003). In pathologies such as ischaemic stroke,
large gaps can develop between adjacent pericytes, increasing
barrier permeability and vessel leakage. These alterations in
pericyte morphology, coupled with an upregulation in the
expression of adhesion molecules and leukocyte integrin ligands,
contribute to the extravasation of peripheral leukocytes into
the brain following ischaemic insult (Pieper et al., 2013).
Thus, pericytes play a large role in cerebral vascular function
under normal physiological conditions as well as vascular
dysfunction in hypoxia.
Several studies have also highlighted the roles of neurons and
glia in BBB development and maintenance. Neural progenitor
cells present in the ventricular neuroepithelium have been
shown to aid endothelial cell recruitment during early BBB
development, which is largely governed by the Wnt signaling
pathway (Risau et al., 1986). Specifically, Wnt signaling in early
CNS development is responsible for vascular stabilization and
angiogenesis (Liebner et al., 2008). Further to this, early neuronal
signaling has been shown to be essential for the maturation of
the BBB, specifically, tight junction (TJ) organization. A study
carried out using rat microvascular endothelial cells and neuronal
progenitor cells, showed that in the presence of neural progenitor
cells, endothelial cells established regular TJ formation including:
claudin 5, zonula occludens (ZO-1) and occludin (Weidenfeller
et al., 2007). After maturation, maintenance of the BBB and
preservation of brain homeostasis is largely dependent on
adequate perfusion to neuronal tissue and neuronal signaling
to cerebral vessels, a process known as hyperaemia (Attwell
et al., 2010). Studies have shown that neuronal-astrocyte crosstalk
is important for appropriate vessel contractility and blood
flow, depending on metabolic demand (Zonta et al., 2003;
Attwell et al., 2010; Macvicar and Newman, 2015). In cerebral
ischaemia, astrocytes sense elevations in Ca2+ ions and increases
in extracellular glutamate released by neurons and respond
accordingly, secreting a range of vasoactive substances to help
mitigate the effects of the blood vessel occlusion (Macvicar and
Newman, 2015). Altogether, interactions between both neural
and vascular cells within the NVU is considered to be paramount
in BBB functionality because together they induce and strengthen
barrier properties; helping to maintain its key features including
low paracellular permeability and functional tightness (Abbott
et al., 2010). Breakdown of the BBB in conditions such as
ischaemic stroke can lead to severe consequences to brain
homeostasis, therefore, modeling these interactions is necessary
to understand the complex signaling networks between these cell
types and how they are influenced in disease states.
To date, a number of BBB models have been developed
ranging from HBMEC monolayers to more sophisticated
spheroid and chip style models, see Table 1. After the successful
isolation of brain endothelial cells, the first, most simplistic
BBB models were developed utilizing HBMECs as a single
monolayer in the abluminal side of transwell inserts, see Table 1
(Borges et al., 1994; Hartz et al., 2010). Later addition of other
BBB cell types (namely astrocytes and pericytes), led to the
development of co-culture transwell systems which exhibited
greater barrier strength, exhibited by higher transepithelial
resistance (TEER) and lower permeability than single HBMEC
models, see Figure 1. More recent transwell systems typically use
three cell types originating from either bovine, porcine or rodent
origin, see Table 1 (Gaillard et al., 2000; Nakagawa et al., 2009;
Thomsen et al., 2015).
Whilst modeling using non-human cells is cheaper and easier
to obtain, they are not comparable to human cells, with many
studies showing key differences in morphology and function,
particularly their sensitivity to glutamate and expression of eﬄux
transporter proteins (Oberheim et al., 2009; Warren et al., 2009;
Zhang et al., 2016). More complex BBB models are also available,
such as spheroid or microfluidic models and offer a closer
representation of the in vivo environment. However, these set
ups are difficult and expensive to assemble (Ruck et al., 2015).
Therefore, there is a need to develop a multicellular transwell
model that incorporates multiple NVU cell types to study their
interactions, particularly the role of neurons and their influence
on barrier strength in both physiological and disease states.
Transwell systems still offer a distinct advantage in that they are
relatively easy to setup and control, as well as offering a range of
endpoints to study. Measuring TEER in these types of models is
commonplace as it provides a reliable, non-invasive quantitative
measure of barrier integrity, enabling repeated measurements
to be taken over the desired time period with minimal damage
to cells (Srinivasan et al., 2015). Further to this, transwell
models enable access to both the apical and basolateral (basal)
compartments for drug application and medium sampling as well
as being able to visualize cells over the course of the experiment.
Our aim was therefore to create a novel four cell human
BBB model to study changes in permeability post oxygen-glucose
deprivation (OGD) and for use in in vitro pharmacology. We
initially focused on model development, refining a protocol first
outlined by Hind (2014) by optimizing the inserts themselves,
insert coating, cell seeding densities and cell culture timelines.
Finally, we incorporated a method of seeding neurons on plastic
coverslips which were placed on the bottom of 12 well cell culture
plates. Thus, our model maintains the ease of the transwell
setup but utilizes four primary human cells, making it a closer
representation of the human in vivo environment.
MATERIALS AND METHODS
Primary cells (astrocytes, pericytes, HBMECs, and neurons)
and specialized cell culture medium (astrocyte medium,
pericyte medium, endothelial cell medium, and neuronal
medium) were obtained from ScienCell, United States
supplied by Caltag Medsystems, United Kingdom. Poly-L-
lysine and porcine fibronectin were also obtained from ScienCell,
United States supplied by Caltag Medsystems, United Kingdom.
Collagen coated inserts, 3.0 µm, 12 mm were obtained from
Corning, United Kingdom. Plastic coverslips (Thermanox
R©
13 mm diameter), Accutase dissociation reagent and glucose
free RPMI medium were obtained from Thermo Fisher
Scientific, United Kingdom.
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TABLE 1 | Different models of the blood brain barrier; their features, advantages, and disadvantages.
Model type Typical components Advantages Limitations Representative of
BBB phenotype
References
Single-cell transwell
systems
(non-co-culture)
A monolayer of HBMECs
cultured in the apical
compartment of the
transwell insert.
Very easy to set up.
Minimal cost.
Low labor intensity.
Useful if wanting to study
endothelial cells alone.
TEER is typically low. Cobblestone appearance of
HBMECs, barrier formation.
Little information on the
impact of additional cell
types.
Borges et al., 1994;
Hartz et al., 2010
Co-culture /multicellular
transwell systems
HBMECs cultured on the apical
side of the transwell insert and
astrocytes and/or pericytes
cultured on the underside of
the transwell insert.
Time and cost effective.
Higher TEER.
Greater barrier stability.
Some models are not
fully in contact.
Closer representation of the
BBB with the addition of
important cell types. Able to
study interactions between
cell types and how they
influence BBB phenotype.
Hind, 2014; Wang
et al., 2015;
Appelt-Menzel
et al., 2017
Spheroid 3D organization of cells typically
using matrigel.
Typically consists of HBMECs
and astrocytes and/or pericytes
with some models containing
neuronal cell types.
3D Cell model.
No scaffold.
Reduced
de-differentiation.
Cannot measure
permeability with
this model.
Expensive and greater
skill required.
Microvessels wrap around
endothelial cells and
provide structural support.
Helps to induce tight
junction proteins. Closely
represents the in vivo set
up with cells in direct
contact with each other.
Applications include:
cancer drug and
neurotoxicity screening.
Cho et al., 2017;
Nzou et al., 2018
Microfluidic systems/3D
chip-style models
3D organization of cells with the
added benefit of a “flow”
system to mimic cerebral blood
flow. Typically consists of
HBMECs and astrocytes and/or
pericytes with some models
containing neuronal cell types.
Advantage of mimicking
sheer stress which is
essential for HBMECs
optimum phenotype.
Difficult to set up and
maintain adequate
flow unless linked to
a computer system.
Useful to assess the impact
of blood flow on cell
development and optimum
phenotype.
Also useful in studying cell
migration and metastatic
progression.
Yeon et al., 2012;
Wang et al., 2017
HBMECs = human brain microvascular endothelial cells, TGFβ = transforming growth factor beta, TEER = transepithelial resistance, BBB = blood brain barrier.
FIGURE 1 | Schematic representation of the BBB model development. (A) A co-culture cell model containing HBMECs and astrocytes. (B) HBMECs seeded on the
apical side, astrocytes seeded on the underside of the insert and pericytes seeded on the plate bottom. (C) HBMECs seeded on the apical side of the insert,
pericytes seeded on the underside of the insert and astrocytes seeded on the plate bottom. (D) HBMECs seeded on the apical side of the insert with mixed culture
of astrocytes and pericytes on the underside of the insert. (E) HBMECs seeded on the apical side of the insert with mixed culture of astrocytes and pericytes on the
underside of the insert and neurons seeded on a poly-L-lysine coated coverslip on the plate bottom.
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Cells were maintained in a humidified incubator (37◦C,
5% CO2). Astrocytes and pericytes were cultured and used
between passages 4 and 6. Human brain microvascular
endothelial cells (HBMECs) were used between passages 3 and
5 and neurons were used at passage 1. During subculture,
flasks containing HBMECs were coated with 2 µg·cm2 of
fibronectin before reviving or splitting cells as per manufacturers
recommendations. Cells were passaged at 80–90% confluency.
Inserts contained 1.2 mL of medium in the basolateral
compartment and 800 µL in the apical compartment.
STX-3 probes and Ohms meter were obtained from World
Precision Instruments, United Kingdom. Dexamethasone was
obtained from Sigma, United Kingdom and dissolved in DMSO
at a stock concentration of 10 mM and subsequently diluted in
cell culture medium. GasPakTM EZ anaerobe container systems
were obtained from BD, United Kingdom.
Model Validation
Our model was based on an initial co-culture set up established
by Hind (2014) and previous models by Allen and Bayraktutan
(2009). Our model was modified and developed in a number
of preliminary experiments including comparison of insert
pore sizes, insert coating, cell organization and addition of
multiple cell types.
Pore Size, Insert Size and Coating
Initially, pore sizes of Corning, United Kingdom inserts were
compared (0.4 µm vs. 3.0 µm) as well as cell culture plates
(12 well vs. 24 well). This was to determine the best initial setup
that provided the highest and most stable barrier resistance,
as well as giving the best cell contact. During protocol
development, we found addition of pericytes in the smaller 24
well plates yielded poor results and insufficient TEER, suggesting
inadequate barrier formation. Possibly as a result of inadequate
cellular growth in such a small surface area and environment.
Therefore, 24 well plates were switched back to 12 well plates,
which resulted in substantially higher TEER readings. Following
work carried out by Niego and Medcalf (2013), we also found
that inserts with a 3.0 µm pore size had higher TEER values
than 0.4 µm inserts, suggesting that increased contact between
the cells in the apical and basolateral sides of the insert resulted
in greater barrier strength, see Figure 2A.
Addition of Multiple Cell Types and
Cell Positioning
Despite these improvements on the co-culture model, the
need for additional cell types was critical to create a closer
representation of the in vivo BBB. We established three different
set ups as shown in Figure 1. In one, astrocytes were seeded on
the basolateral side of the inserts and pericytes on the bottom of
the culture dish (Figure 1B), in another pericytes were seeded on
the basolateral of the inserts whilst astrocytes were seeded on the
bottom of the culture dish (Figure 1C) and finally the last set up
involved a mixed culture of astrocytes and pericytes seeded on
the basolateral side of the insert (Figure 1D). In all models tested,
HBMECs were seeded in the apical side of the transwell insert.
FIGURE 2 | Model protocol development (A) measured transepithelial
resistance (TEER) as a marker of barrier tightness comparing a 12 well plate
transwell set up vs. a 24 well plate transwell set up and insert pore size
3.0 µm vs. 0.4 µm. HBMECs seeded on the apical side of the insert,
astrocytes underneath and pericytes on the plate bottom. (B) The
organization of cells was optimized by comparing the TEER generated by a
mixed culture of astrocytes and pericytes, pericytes or astrocytes alone on the
underside of transwell inserts and astrocytes or pericytes on the cell culture
plate bottom. HBMECs were seeded on the apical side of the insert. Data
given as mean ± SEM, n = 4–6 from two experimental repeats. Statistical
analysis conducted using 2-way ANOVA with Turkey’s multiple comparisons
test, ∗∗P < 0.01 and ∗∗∗P < 0.001 mixed culture astrocytes and pericytes vs.
pericytes underside the insert and astrocytes on plate bottom. #P < 0.05
mixed culture astrocytes and pericytes vs. astrocytes underside the insert and
pericytes on plate bottom.
The final set up offered a closer replication of the organization
held at the in vivo BBB, as cells would be in direct contact allowing
them to exchange vital growth factors required for cellular growth
and development. We found that mixed culture of pericytes
and astrocytes exhibited significantly higher TEER values when
compared to the set-up with pericytes seeded on the plate bottom
and astrocytes underneath the insert or astrocytes on the plate
bottom and pericytes underneath the insert on days 3 and 4,
P < 0.05 and P < 0.01, respectively (Figure 2B). Furthermore,
this set up was also considered the most stable, as shown by
steadier TEER readings and was altogether more physiologically
relevant. This set up was therefore taken forward in subsequent
four cell protocol development.
To test the viability of adding neurons to the model,
we originally seeded neurons on the bottom of the 12 well
plate in which the inserts were hung. This, however, was
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not feasible as the TEER probes touched the bottom of
the plate causing unwanted damage to the cells. Therefore,
we decided to utilize coverslips that could be positioned
on the plate bottom, but not take up the entirety of the
well, allowing the probe to sit where the cells were not
present. After testing both poly-L-lysine coated glass and plastic
coverslips, we found that plastic coverslips coated were the most
effective in neuronal adhesion and this method was used in
the final model.
Four Cell Method Overview
After optimization, our four cell BBB model consisted of four
major NVU cell types arranged in a transwell permeability set-up
(see Figure 1E). The assembly of this involves seeding different
cell types at different times on the apical and basolateral sides
of the transwell insert. During this time, neurons are seeded
on plastic coverslips placed on the bottom of a separate 12
well plate to develop neurite before putting both parts of the
model together on the final day of model establishment. Cell
culture medium in both compartments was replaced every other
day and the final set up was left to equilibrate for 2 days
before commencing experiments. Greater than 85% of inserts are
feasible for use in experiments and the model remained viable
for up to 5 days.
Insert Coating and Astrocyte Seeding
On day one, the basolateral side of transwell inserts were
coated with poly-L-Lysine and astrocytes were seeded on the
basolateral side of the inserts, see Figure 3. Briefly, 3.0 µm,
12 mm collagen coated inserts (Corning, United Kingdom) were
carefully removed from outer packaging and placed into 12 well
cell culture plates using sterile forceps. A solution of poly-L-
Lysine (2 µg/cm2) was prepared in sterile water, homogenously
mixed and carefully pipetted using a Pasteur pipette to just cover
the basolateral of the insert, see Figures 4A,i. Plates containing
inserts were then returned to the incubator, 37◦C, 5% CO2
for 1 h as per supplier recommendations. After 1 h, plates
were removed from the incubator and washed twice with sterile
water to remove any residual poly-L-lysine. All remaining liquid
was removed by careful aspiration. Transwell inserts were then
flipped inside the plate and the lid removed (Figure 4B). On
the newly coated inserts, 100 µL of astrocyte cell suspension
in astrocyte medium (3.13 × 105 cells) was pipetted quickly
onto the basolateral side of the transwell and the lid carefully
replaced (see Figures 4C,ii). Plates were returned to the cell
culture incubator for 2–3 h for the cells to adhere. After this
time, transwell inserts were reverted and any excess medium was
removed by aspiration. Medium was topped up in the apical
and basolateral compartments, see Figure 4iii. Again, plates were
returned to the incubator.
Pericyte Seeding
On day 2, plates were removed from the incubator and the
astrocyte medium was removed with care so as to not disturb the
layer of cells on the basolateral side of the insert. Inserts were then
inverted again and 100 µL of 6.25 × 104 pericyte cell suspension
was added to the astrocyte cell layer on the basolateral side of the
transwell inserts, giving an approximate ratio of 5:1 astrocytes to
pericytes (Pardridge, 1999). Plate lids were quickly replaced and
returned to the incubator for 2–3 h. After this time, transwell
inserts were reverted and any excess medium was removed by
aspiration and a mixture of astrocyte and pericyte medium (1:1)
was added to the apical and basolateral compartments.
HBMEC Seeding
Once astrocytes and pericytes reached 90% confluency (approxi-
mately day 4 from model initiation, see Figure 3), the
astrocyte:pericyte (1:1) medium in the apical compartment was
removed and 100 µL of HBMEC cell suspension (7.5 × 104)
in HBMEC medium was added to the apical compartment of
transwell inserts and cells were left to adhere for a minimum of
5 h, then medium was topped up to 700 µL with endothelial cell
medium and plates returned to the incubator.
Neuronal Seeding
On the same day as HBMEC seeding, plastic coverslips (13 mm
diameter) were coated with poly-L-lysine and placed in the
cell culture incubator for a minimum of 1 h, as per supplier
recommendations. Plates containing coverslips were carefully
removed from the incubator and coverslips were washed twice
with sterile water and left to air dry in the cell culture hood.
Following this, cryopreserved neurons were revived into 3 mL
of neuronal medium (to give a total cell suspension of 4 mL)
and 100 µL of cell suspension was added to each coverslip (thus
seeded at a density of approximately 2.5 × 104 cells per cm2
within the optimum range according to the manufacturer’s
FIGURE 3 | Timeline showing stages of model establishment. On day 1, inserts were coated and astrocyte seeded on the basolateral side of transwell inserts and
on day 3 pericytes were seeded on the basolateral side of inserts to form a mixed culture. On day 6 HBMECs were seeded on the apical side of inserts and neurons
were seeded on coated plastic coverslips in a separate 12 well plate. On day 10/11, inserts are carefully lifted out of their current plate and placed into the second
12 well plate containing the neurons seeded on coverslips. After 2 days, TEER measurements are taken to ensure adequate barrier formation. ∗ In our lab OGD
experiments were commenced at this point and were viable for 4–5 days.
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FIGURE 4 | Model setup (A–D) and (i–v). (A/i) Inserts are placed into 12 well plate, coated with poly-L-lysine and washed, ensuring all of the liquid is removed.
(B/ii) Inserts are carefully flipped inside the plate and the plate removed. 100 µL of relevant cell suspension is carefully placed on the underside of the insert.
(C/ii) The bottom of the cell culture plate acts as a “lid” and is replaced as quickly as possible, plates are then returned to the incubator for the cells to adhere for
3–4 h. (iv) In a separate 12 well plate, coverslips are placed in the bottom of the culture dish, coated with poly-L-lysine and seeded with neuronal cell suspension.
(v) Once all cells have been seeded on transwells, inserts are carefully transferred to plates containing neurons on coverslips.
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recommendations) (Figures 4D,iv). Medium was topped up
after 2 h and half of the medium replaced every 2–3 days.
After light microscope observation, neurons began showing
extensive neurite growth at approximately day 5. At this point
HBMECs will have almost formed a confluent monolayer above
the astrocytes and pericytes. Transwells were then carefully lifted
out of their current 12 well plate using sterile forceps and
placed into the 12 well plate containing the neuronal coverslips.
Fresh HBMEC medium was applied to the apical compartment
and a mix of pericyte, astrocyte and neuronal medium (1:1:2,
respectively) was added to the basolateral compartment. This was
to maintain a low concentration of fetal bovine serum optimum
for neuronal maintenance, whilst also preserving growth of
astrocytes and pericytes. As all cells were confluent and the
barrier was adequately formed, conditions were able to be
maintained in the different compartments.
Oxygen-Glucose Deprivation
(OGD) Protocol
An oxygen-glucose deprivation (OGD) protocol was used
to increase barrier permeability, simulating the effects of
ischaemic stroke in vitro (Hind et al., 2015, 2016). Normal
cell culture medium was removed from transwell inserts
and replaced with glucose free RPMI medium (Thermo
Fisher Scientific, United Kingdom) and placed in a 0% O2
environment (GasPakTM anaerobe pouch Beckton Dickinson,
Oxford, United Kingdom) for 20 min to ensure anaerobic
conditions for a further 4 h. There was no initial pre-
conditioning period. Reperfusion was initiated by removing
plates from the anaerobe pouch and returning cells to their
normal medium (HBMEC medium in the apical compartment
and in the basolateral compartment a mix of pericyte, astrocyte
and neuronal medium, 1:1:2, respectively). TEER was measured
at baseline (0 h), immediately post OGD (4 h), 24, 48, and 72 h.
Evaluation of Barrier Integrity
Transepithelial resistance (TEER) was measured prior to
commencing OGD experiments to ensure model barrier
integrity; inserts should exhibit a TEER value of ≥45 /cm2
(Figure 4v). Light microscope observation was also carried out
to ensure cell confluency and successful neurite formation. To
ensure consistency, TEER measures should always be read at
least 24 h after a medium change. Briefly, STX3 electrodes were
sterilized by placing the tips of the probe in 70% ethanol, and
then equilibrated for 15 min in endothelial cell culture medium
at room temperature. The STX probe was then connected
to an EVOM2 meter (Both World Precision Instruments,
United Kingdom) and inserted into the transwell insert. The
electrode has two parts that are uneven in length, the longer part
of the electrode was placed so it gently touched the bottom of
the cell culture plate, whilst the shorter electrode rested slightly
above the insert dish, not quite making contact the HBMEC
cell layer. Care should be taken to avoid disrupting the neurons
on the bottom of the cell plate, see technical comments and
limitations. As TEER values are very susceptible to change, it is
important to keep the electrode upright and avoid tilting as
this can cause fluctuation in the TEER values. A background
reading for an insert with just cell culture medium was taken
and subtracted from each reading (readings were repeated twice
to ensure reproducibility), this was then multiplied by 1.12 to
address the cell culture insert area (cm2) (Hind, 2014).
Dexamethasone Protocol
Dexamethasone is a synthetic glucocorticoid and several groups
have shown that is able to artificially improve barrier strength
(Shi and Zheng, 2005; Pyrgos et al., 2010; Hind, 2014). Therefore,
we used dexamethasone as a positive control to investigate any
potential difference in the response of the three versus four
cell model to a drug application. Baseline TEER readings were
recorded and medium replaced, then dexamethasone was added
to the apical compartment of the transwell insert, giving a final
concentration of 1 µM. TEER was measured at 2, 4, and 24 h.
Data Analysis
Data analysis was carried out using GraphPad prism software
(La Jolla, CA, United States). Data are presented as mean± SEM
and analyzed using two-way ANOVA, followed by Sidak’s
or Turkey’s multiple comparisons test. ∗P < 0.05 was
considered significant.
Technical Comments and Limitations
A critical step for setting up the four cellular model is timing
and the revival and seeding of human neurons. Addition of the
cells at incorrect timings will result in the model not working
as effectively and TEER values will be lower than anticipated.
We have therefore outlined a timeline for setting the model up
(Figure 2), steps 4 and 5 can vary depending on the time taken for
barrier formation to take place and for neurons to form neurite.
Improper technique when seeding neurons on the coverslips will
result in a lack of uniformity and inadequate neurite formation.
Ensure coverslips are adequately air dried and neuronal cell
suspension is carefully but adequately mixed during the revival
and seeding process. Avoid removing neurons from the incubator
for long periods.
When taking TEER values, ensure that the larger part of
the STX probe does not touch the neurons cultured on the
coverslip. This is especially important if multiple readings are
being made (recommended). Utilization of neurons after primary
experiments have been completed is also possible. Staining can
be done on the coverslips using a variety of techniques including
propidium iodide (PI) and DAPI staining, neurons can be lysed
and intracellular assays can be performed.
RESULTS
Protocol Development
During BBB model development various set ups were compared
including; insert pore size, plate size, and cell organization.
Figure 2 highlights stages in protocol development and their
respective TEER values, prior to the addition of neurons into
the model. Figure 2A shows that a larger pore size (3.0 µm)
exhibited greater barrier integrity (as shown by greater TEER
readings) than the smaller pore size (0.4 µm). Furthermore, the
Frontiers in Cellular Neuroscience | www.frontiersin.org 7 June 2019 | Volume 13 | Article 230
fncel-13-00230 June 4, 2019 Time: 18:4 # 8
Stone et al. Transwell Blood Brain Barrier Model
12 well inserts displayed considerably greater TEER readings
than the 24 well inserts. Continuing model development using
12 3.0 µm inserts, Figure 2B compares three different cell
culture set-ups days after model establishment. On days three
and four, the inserts containing a mixed culture of astrocytes and
pericytes displayed significantly higher TEER readings than set-
ups containing astrocytes or pericytes seeded on the underside
of the inserts or the cell culture plate bottom, P < 0.05 and
P < 0.01, respectively.
OGD Model Simulation
To assess the effect of having different cells present, changes
in TEER from models D and E shown in Figure 1, were
compared following an OGD protocol. Figure 5A highlights
the different responses of a three cell and four cell model in
response to a 4 h OGD protocol, followed by a reperfusion
period. The three-cell mode exhibited approximately a 30%
drop in TEER from baseline after 4 h OGD. This contrasts
to the four-cell model which exhibited a 50% drop in TEER
post OGD and was significantly different to the three-cell
model P < 0.05. After OGD, when reperfusion was initiated,
TEER was able to return to baseline in the three-cell model,
however, BBB permeability only marginally recovered by 20%
in the four-cell model. This was significantly different at 24 h
(P < 0.01) but not 48 or 72 h. Images 5B and C show
FIGURE 5 | (A) Effect of a 4 h oxygen-glucose deprivation (OGD) protocol on
transepithelial resistance (TEER) as a marker of barrier tightness in a three cell
model (HBMECs, astrocytes, and pericytes) and a four cell model (HBMECs,
astrocytes, pericytes, and neurons). Neuronal images taken from the four cell
model (B) before OGD 40× and (C) neuronal images immediately post OGD
40×. Data given as mean ± SEM, n = 3–6 from two experimental repeats,
calculated as a % change from baseline TEER readings. Statistical analysis
was conducted using 2-way ANOVA with Sidak’s multiple comparisons test,
∗P < 0.05 and ∗∗P < 0.01 was considered significant.
light microscope images of neurons in the four-cell model
before and immediately after the OGD protocol, respectively.
In Figure 5C neuronal clumping is clearly visible along with
apparent neurite fragmentation compared to Figure 5B showing
healthy neurons prior to OGD.
Dexamethasone Application
Dexamethasone increased barrier tightness in all three models, as
shown by increases in TEER and exhibiting overall significance
as a result of drug interaction in the three cell and four cell
model, P < 0.05. The two-cell model was the most unstable
out of the three models, as shown by greater fluctuations and
variability in TEER measurements (Figure 6A). The three-cell
model was considerably more stable but differences in TEER
between dexamethasone treated and control were only observed
after 2 h (Figure 6B). The four-cell model was the fastest to
exhibit an increase in barrier tightness (i.e., increased TEER)
as a result of dexamethasone application (Figure 6C) and
this reached significance compared to the vehicle control at 2
and 24 h (P < 0.05).
DISCUSSION
The BBB can be compromised in a range of different conditions,
including but not limited to ischaemic stroke, Alzheimer’s
disease, cancer, and multiple sclerosis (MS). Research into
these disorders that affect the BBB is plagued by translational
difficulty, resulting in many potential compounds and/or
therapies failing to surpass phase I/II clinical trials. This is
at least partly due to a lack of suitable in vitro models that
can predict drug effectiveness pre-clinically. Most, if not all,
current BBB models exhibit “pitfalls” whether that be cost,
time or resources. Models that offer the closest representation
of the BBB are often complex and expensive to replicate,
adding to the cost of the drug screening process. To help
improve the translatability of in vitro data, we developed a
transwell style model that incorporates four primary human
cell types, representing the NVU more than other BBB models
currently available. We found that our novel four-cell model
was superior in modeling ischaemic stroke and drug application
in vitro compared to a three-cell and a two-cell model as shown
through changes in TEER as a measure of barrier integrity and
dexamethasone application.
Implications for Drug Testing
The effect of dexamethasone was assessed in three transwell
models; a two cell, three cell and four cell model. Greater
instability in barrier strength and a slower response was
exhibited by the two-cell model after dexamethasone application.
This could also suggest that models containing just two
cell types, in this case astrocytes and HBMECs, would also
react differently to other drug applications and are therefore
are not sufficient to truly model drug interactions at the
BBB. Whilst the three-cell model shared the same trend in
increasing barrier strength, it exhibited more stable TEER
values compared to the two-cell model and dexamethasone
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FIGURE 6 | The effect of dexamethasone on transepithelial resistance (TEER)
as a measure of barrier tightness in (A) a two cell (astrocytes and HBMECs),
(B) three cell (astrocytes, HBMECs, and pericytes), and (C) four cell model
(astrocytes, HBMECs, pericytes, and neurons). Dexamethasone (1 µM) was
added to the luminal side and used as positive control that is known to
decrease permeability, thus increase TEER. Data represented as
mean ± SEM, n = 4 from two experimental repeats. Statistical analysis was
conducted using 2-way ANOVA with Sidak’s multiple comparisons test,
∗P < 0.05 was considered significant.
treated wells were overall significantly different to the vehicle
control. Also, by introducing pericytes (generating a three
cell model) there was a large increase in baseline TEER
from 30 to 40 , again highlighting the role of pericytes
in strengthening vascular stability at the BBB and the need
for their presence in BBB models (Bergers and Song, 2005;
Dohgu et al., 2005; Nakagawa et al., 2007; Ferland-McCollough
et al., 2017) Interestingly, the four-cell model exhibited a
significant increase in barrier tightness (as shown by an increase
in TEER) compared to the vehicle control at just 2 h after
dexamethasone application. Although neurons in this model
do not directly interact with the BBB, neurons have been
shown to secrete a number of vasoactive substances, including
VEGF, which influence barrier forming properties and early
angiogenesis (Engelhardt, 2003; Eichmann and Thomas, 2013).
These comparison data highlight the variations in data obtained
from models containing different cell types and the impact this
can have on drug screening. This stresses the importance of
having a more representative BBB model containing additional
cells present at the NVU.
Implications for Protocol Testing
Currently there are a wide range of in vitro BBB models
available, but despite promising developments in modeling
the BBB, there are still gaps in model design, primarily the
inability to include all cell types present in the NVU. Whilst
most transwell systems incorporate astrocytes and HBMECs,
only more recent studies have introduced pericytes or neurons
into these model designs. To gain a better understanding
of how these cells contribute to the breakdown of the BBB
in ischaemic conditions, we subjected our three cell and
four cell models to an OGD protocol and measured TEER
overtime to assess changes in barrier integrity. Interestingly,
we found that with the presence of neurons our model
exhibited a larger decrease in TEER compared to the three-
cell model, which only contained astrocytes, pericytes and
HBMECs. Similarly, whilst the three-cell model was able to
recover 24 h post OGD the four-cell model only marginally
recovered by approximately 20%, highlighting the role of
and sensitivity of neurons in the level of damage ensued by
the OGD protocol. Altogether, we have shown that with the
addition of neurons our model became more vulnerable to
damage; exhibiting a greater loss of barrier strength shown by
a decrease in TEER, supporting previous work which showed
that ischaemic neurons disrupt the endothelial barrier through
increasing VEGF secretion (Li et al., 2014). Thus, omitting
neurons from a BBB modeling stroke would underestimate the
damage caused and contribution of neurons to the breakdown of
the BBB post ischaemia.
Limitations and Future Development
Although our model now includes four cell present in the
NVU, our model does not incorporate flow which is an
important feature to maintain the BBB phenotype in vitro.
Studies have shown that sheer stress is critical to increase
cell longevity and influence cell phenotype, regulate BBB
transport, preventing de-differentiation (Desai et al., 2002;
Chiu et al., 2005; Partyka et al., 2017). Culturing HBMECs
under physiological shear stress, is particularly important in
a ischaemic stroke setting because there is an interruption in
blood flow. Microfluidic systems that mimic physiological flow
have the advantage in that they can simulate continuous flow
improving translation to the environment (Partyka et al., 2017;
Wang et al., 2017).
Equally, there is increasing evidence of the role of microglial
cells in BBB breakdown. These resident brain immune cells
have been shown to release pro-inflammatory mediators that
increase barrier permeability and reduce levels of certain TJs,
thus playing a key role in BBB breakdown in pathological states
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(da Fonseca et al., 2014; Shigemoto-Mogami et al., 2018)
Therefore, future work should assess whether additional cells and
shear stress can be incorporated into transwell style models.
CONCLUSION
The overall function of the NVU is the perfusion of brain tissue
to supply neurons with essential nutrients and the ability of
neurons to regulate this blood flow. Glia, namely astrocytes, act
as mediators between the vascular and neural compartments (Lo
et al., 2015). Pericytes provide an extra level of communication
between the endothelia and astrocytes as well as serving a
prominent immune function (Darland et al., 2003; Armulik
et al., 2011; Kovac et al., 2011). During cerebral ischaemia, these
complex interactions are disrupted, and homeostasis is lost as a
consequence of functional, morphological and metabolic changes
within the NVU (Lo et al., 2015). It is important to model how
these cells interact in both normoxic and ischaemic conditions to
study the pathophysiology of ischaemic stroke. Finally, transwell
systems offer noticeable advantages over the more complex
models as they maintain the ease simpler cell culture set up
and often use minimal resources. We believe our model offers a
closer representation of the BBB, whilst maintaining the ease of a
transwell setup.
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